tirzepatide cary Raleigh, N.C Free consultation. Tirzepatide Reduces Food Intake and

Dual Incretin Research Peptide GLP-1/GIP Receptor Agonist Overview This dual incretin research peptide is a synthetic GLP-1R/GIPR co-agonist studied in preclinical metabolic research models for its coordinated activation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor pathways

This led to an FDA warning that remains on GLP-1 RA drugs today, advising against their use in patients with a personal or family history of medullary thyroid carcinoma

Contraindications and Cautions: Avoid if pregnant or lactating

Wipe the vial tops with alcohol, draw the right amount of bacteriostatic water, inject it slowly down the inside wall of the peptide vial, gently swirl until clear, then label and refrigerate

Richard Bloomer contributes as an Academic Dean, Research Scientist, and dietary supplement expert

products on this website are for research use only and are not intended for human or animal consumption